Record NNP B-NP O
date NN I-NP O
: : O O
2080-03-24 CD O B-DATE
PICH NNP B-NP B-HOSPITAL
CLINIC NN I-NP O
VISIT NN I-NP O
PT NNP B-NP O
: : O O
Nora NNP B-NP B-PATIENT
Greenwood NNP I-NP I-PATIENT
Date NNP B-NP O
of IN B-PP O
Visit NNP B-NP O
: : O O
3/24/8 CD B-NP I-DATE
0 CD I-NP I-DATE
Contact JJ B-NP O
information NN I-NP O
: : O O
715-007-3511 CD O B-PHONE
Id/cc NNP B-NP O
: : O O
48 CD B-NP B-AGE
F NN I-NP O
with IN B-PP O
PMH NNP B-NP O
of IN B-PP O
type NN B-NP O
II NNP I-NP O
DM NNP I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
obesity NN B-NP O
, , O O
hidradenitis NN B-NP O
suppurativa NN I-NP O
, , O O
and CC O O
new JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
fibromyalgia NN B-NP O
presenting VBG B-VP O
to TO I-VP O
PICH VB I-VP B-HOSPITAL
for IN B-PP O
follow-up JJ B-NP O
visit NN I-NP O
re RB B-ADVP O
: : O O
1 CD B-NP O
) -RRB- I-NP O
DM NNP I-NP O
; : O O
2 CD B-NP O
) -RRB- I-NP O
HTN NN I-NP O
; : O O
3 CD B-NP O
) -RRB- I-NP O
hidradenitis NN I-NP O
suppurativa NN I-NP O
4 CD B-NP O
) -RRB- I-NP O
fibromyalgia/joint JJ I-NP O
pain NN I-NP O
. . O O
HPI NNP B-NP O
: : O O
Interval NNP B-NP O
hx VBD B-VP O
to TO I-VP O
be VB I-VP O
reviewed VBN I-VP O
by IN B-PP O
each DT B-NP O
issue NN I-NP O
. . O O
1 CD B-NP O
) -RRB- I-NP O
DM NNP I-NP O
: : O O
Most RBS B-NP O
recent JJ I-NP O
HgbA1c NNP I-NP O
on IN B-PP O
12/31/79 CD B-NP B-DATE
: : O O
7.1 CD B-NP O
( -LRB- O O
down IN B-ADVP O
from IN B-PP O
8.2 CD B-NP O
) -RRB- I-NP O
. . B-NP O
Nora NNP I-NP B-PATIENT
reports VBZ B-VP O
fasting VBG I-VP O
BS NNP B-NP O
in IN B-PP O
the DT B-NP O
140-150 CD I-NP O
and CC O O
pre-dinner JJ B-NP O
BS NNP I-NP O
~low NNP I-NP O
l00 VBD B-VP O
's PRP B-NP O
, , O O
but CC O O
does VBZ B-VP O
not RB I-VP O
always RB I-VP O
check VB I-VP O
her PRP B-NP O
FS NNS B-NP O
on IN B-PP O
a DT B-NP O
regular JJ I-NP O
basis NN I-NP O
. . O O
Noticed VBD B-VP O
that IN B-PP O
her PRP$ B-NP O
FS NNS I-NP O
were VBD B-VP O
running VBG I-VP O
much RB B-ADVP O
high JJ B-NP O
( -LRB- I-NP O
>200 CD I-NP O
) -RRB- O O
when WRB B-ADVP O
she PRP B-NP O
was VBD B-VP O
taking VBG I-VP O
the DT B-NP O
elavil JJ I-NP O
for IN B-PP O
her PRP$ B-NP O
fibromyalgia NN I-NP O
. . O O
She PRP B-NP O
stopped VBD B-VP O
the DT B-NP O
elavil JJ I-NP O
bc NN I-NP O
of IN B-PP O
these DT B-NP O
elevated JJ I-NP O
FS. NNP I-NP O
Continues NNP I-NP O
to TO B-VP O
take VB I-VP O
Glucotrol NNP B-NP O
XL NNP I-NP O
2.5mg CD I-NP O
qd NN I-NP O
. . O O
Denies NNS B-NP O
any DT B-NP O
episodes NNS I-NP O
of IN B-PP O
hypoglycemia NN B-NP O
, , O O
but CC O O
aware JJ B-ADJP O
of IN B-PP O
possible JJ B-NP O
symptoms NNS I-NP O
and CC O O
knows VBZ B-VP O
to TO I-VP O
keep VB I-VP O
candy NN B-NP O
with IN B-PP O
her PRP B-NP O
at IN B-PP O
all DT B-NP O
times NNS I-NP O
. . O O
Saw VBD B-VP O
nutrition NN B-NP O
on IN B-PP O
6/5/79 CD B-NP B-DATE
and CC O O
feels VBZ B-VP O
that IN B-PP O
her PRP$ B-NP O
diet NN I-NP O
has VBZ B-VP O
improved VBN I-VP O
since IN B-PP O
this DT B-NP O
session NN I-NP O
. . O O
Continues NNS B-VP O
to TO I-VP O
be VB I-VP O
quite RB B-ADJP O
active JJ I-ADJP O
, , O O
walking VBG B-VP O
a DT B-NP O
lot NN I-NP O
at IN B-PP O
her PRP$ B-NP O
job NN I-NP O
( -LRB- I-NP O
RN NNP I-NP B-PROFESSION
) -RRB- I-NP O
and CC O O
at IN B-PP O
home NN B-NP O
. . O O
2 CD B-NP O
) -RRB- I-NP O
HTN NN I-NP O
: : O O
Continues NNP B-NP O
to TO B-VP O
take VB I-VP O
lisinopril VB I-VP O
20mg JJ B-NP O
qd NN I-NP O
; : O O
BP NNP B-NP O
slightly RB B-ADVP O
elevated VBD B-VP O
at IN B-PP O
last JJ B-NP O
visit NN I-NP O
at IN B-PP O
144/68 CD B-NP O
. . O O
Plan NNP O O
to TO B-VP O
repeat VB I-VP O
BP NNP B-NP O
check NN I-NP O
today NN I-NP O
and CC O O
if IN B-SBAR O
still RB B-ADVP O
elevated VBN B-VP O
to TO I-VP O
increase VB I-VP O
lisinopril NN B-NP O
. . O O
Denies NNS B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
DOE NNP B-NP O
, , O O
LE JJ B-NP O
edema NN I-NP O
, , O O
pnd NN B-NP O
, , O O
orthopnea NN B-NP O
, , O O
recent JJ B-NP O
visual JJ I-NP O
changes NNS I-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
headaches NNS B-NP O
. . O O
Has VBZ B-VP O
been VBN I-VP O
shoveling VBG I-VP O
snow NN B-NP O
on IN B-PP O
a DT B-NP O
regular JJ I-NP O
basis NN I-NP O
without IN B-PP O
sob JJ B-NP O
or CC I-NP O
chest NN I-NP O
pain NN I-NP O
. . O O
3 CD B-NP O
) -RRB- I-NP O
hidradenitis NN I-NP O
suppurativa NN I-NP O
: : O O
Nora NNP B-NP B-PATIENT
recently RB B-ADVP O
completed VBD B-VP O
14day JJ B-NP O
course NN I-NP O
of IN B-PP O
levaquin NN B-NP O
for IN B-PP O
a DT B-NP O
flare NN I-NP O
of IN B-PP O
her PRP$ B-NP O
hs NNS I-NP O
. . O O
In IN B-PP O
past NN B-NP O
, , O O
treated VBN B-VP O
with IN B-PP O
diclox NN B-NP O
and CC I-NP O
augmentin NN I-NP O
; : O O
however RB B-ADVP O
, , O O
nora NN B-NP B-PATIENT
felt VBD B-VP O
that IN B-SBAR O
both DT B-NP O
became VBD B-VP O
less RBR B-ADJP O
effective JJ I-ADJP O
with IN B-PP O
time NN B-NP O
. . O O
Also RB B-VP O
treated VBN I-VP O
with IN B-PP O
Bactrim NNP B-NP O
which WDT B-NP O
was VBD B-VP O
d/c JJ B-NP O
'd MD B-VP O
2/2 VB I-VP O
stomach NN B-NP O
upset JJ I-NP O
. . B-PP O
Feels NNS B-NP O
that WDT B-NP O
acute JJ I-NP O
inflammation NN I-NP O
is VBZ B-VP O
better RB B-ADVP O
, , O O
but CC O O
still RB B-ADVP O
with IN B-PP O
baseline NN B-NP O
, , O O
fairly RB B-NP O
severe JJ I-NP O
inflammation NN I-NP O
, , O O
discharge NN B-NP O
, , O O
and CC O O
pain NN B-NP O
. . O O
Had VBD B-VP O
been VBN I-VP O
seen VBN I-VP O
by IN B-PP O
general JJ B-NP O
surgery NN I-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
who WP B-NP O
felt VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
needed VBD B-VP O
to TO I-VP O
be VB I-VP O
seen VBN I-VP O
by IN B-PP O
plastics NNS B-NP O
. . O O
Was VBD B-VP O
scheduled VBN I-VP O
to TO I-VP O
see VB I-VP O
plastics NNS B-NP O
in IN B-PP O
consultation NN B-NP O
, , O O
but CC O O
was VBD B-VP O
told VBN I-VP O
that IN B-SBAR O
she PRP B-NP O
had VBD B-VP O
to TO I-VP O
pay VB I-VP O
200.00 CD B-NP O
for IN B-PP O
visit NN B-NP O
even RB B-SBAR O
though IN I-SBAR O
she PRP B-NP O
was VBD B-VP O
free JJ B-NP O
care NN I-NP O
and CC O O
could MD B-VP O
not RB I-VP O
afford VB I-VP O
this DT B-NP O
. . O O
Continues NNP O O
to TO B-VP O
use VB I-VP O
clindamycin NNS B-NP O
topical JJ B-NP O
gel NN I-NP O
. . O O
Denies NNS B-VP O
fever NN B-NP O
, , O O
chills NNS B-NP O
, , O O
night NN B-NP O
sweats VBZ B-VP O
, , O O
or CC O O
n/v. $ O O
4 CD B-NP O
) -RRB- I-NP O
FIBROMYALGIA/JOINT NNP I-NP O
PAINS NNS I-NP O
: : O O
Nora NNP B-NP B-PATIENT
was VBD B-VP O
recently RB I-VP O
seen VBN I-VP O
in IN B-PP O
urgent JJ B-NP O
care NN I-NP O
on IN B-PP O
2/13/8 CD B-NP I-DATE
0 CD I-NP I-DATE
with IN B-PP O
c/o JJ B-NP O
diffuse JJ I-NP O
joint NN I-NP O
pains NNS I-NP O
and CC O O
myalgias JJ B-NP O
x NN I-NP O
2 CD B-NP O
weeks NNS I-NP O
. . O O
Urgent NN B-VP O
care NN B-NP O
w/u NN I-NP O
included VBD B-VP O
a DT B-NP O
negative JJ I-NP O
ana NN I-NP O
, , O O
RF NNP B-NP O
, , O O
and CC O O
normal JJ B-NP O
parvovirus NN I-NP O
IGM NNP I-NP O
level NN I-NP O
, , O O
but CC O O
IgG NNP B-NP O
was VBD B-VP O
7.79 CD B-NP O
% NN I-NP O
( -LRB- I-NP O
normal JJ I-NP O
less JJR B-NP O
than IN I-NP O
1.1 CD I-NP O
) -RRB- I-NP O
. . O O
Seen NNP O O
by IN B-PP O
Dr. NNP B-NP O
Marshall NNP I-NP B-DOCTOR
in IN B-PP O
Rheum NNP B-NP O
who WP B-NP O
did VBD B-VP O
not RB I-VP O
feel VB I-VP O
that IN B-SBAR O
she PRP B-NP O
had VBD B-VP O
a DT B-NP O
"bona NNP I-NP O
fide NN I-NP O
synovitis NN I-NP O
" '' O O
but CC O O
considered VBD B-VP O
ddx JJ B-NP O
including VBG I-NP O
fibromyalgia NN I-NP O
and CC I-NP O
inflammatory NN I-NP O
arthritis NN I-NP O
. . O O
Further RBR B-ADJP O
work-up JJ I-ADJP O
included VBD B-VP O
a DT B-NP O
negative JJ I-NP O
anti-ccp JJ I-NP O
, , I-NP O
normal JJ I-NP O
EST NNP I-NP O
, , O O
and CC O O
a DT B-NP O
negative JJ I-NP O
ASLO NN I-NP O
. . O O
He PRP B-NP O
started VBD B-VP O
her PRP B-NP O
on IN B-PP O
elavil JJ B-NP O
to TO B-VP O
improve VB I-VP O
her PRP$ B-NP O
sleep NN I-NP O
, , O O
but CC O O
nora DT B-NP B-PATIENT
stopped VBD B-VP O
2/2 RP I-VP O
elevated JJ B-NP O
bs NNS I-NP O
. . O O
Does VBZ B-VP O
feel NN B-NP O
that IN B-PP O
improved JJ B-NP O
sleep NN I-NP O
significantly RB B-ADVP O
improves VBZ B-VP O
her PRP$ B-NP O
symptoms NNS I-NP O
. . O O
Problems NNS B-NP O
Type JJ B-NP O
2 CD I-NP O
diabetes NN I-NP O
Hyperlipidemia NNP B-NP O
h/o WDT B-NP O
childhood NN I-NP O
asthma NN I-NP O
H/O NNP B-NP O
pyelonephritis NN I-NP O
FH NNP B-NP O
ovarian JJ I-NP O
cancer NN I-NP O
: : O O
mother NN B-NP O
, , I-NP O
grandmother NN I-NP O
, , O O
and CC O O
sister NN B-NP O
smoker NN B-NP O
Hypertension NN B-NP O
Obesity NN B-NP O
Medications NNS B-NP O
Gluctrol NNP B-NP O
XL NNP I-NP O
2.5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD NNP I-NP O
, , O O
Take VB B-VP O
1 CD B-NP O
tablet NN I-NP O
a DT B-NP O
day NN I-NP O
Miconazole NNP B-NP O
CREAM NNP I-NP O
2 CD I-NP O
% NN I-NP O
TOPICAL NN I-NP O
( -LRB- I-NP O
MICONAZOLE NNP I-NP O
NITRATE NNP I-NP O
2 CD I-NP O
% NN I-NP O
) -RRB- O O
1 CD B-NP O
APPLICATION NN I-NP O
( -LRB- I-NP O
2 CD I-NP O
% NN I-NP O
CREAM(GM NN I-NP O
) -RRB- I-NP O
) -RRB- B-PP O
TOP NNP B-NP O
TID NN I-NP O
Nystatin NNP B-NP O
POWDER NNP I-NP O
TOPICAL NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
x NN I-NP O
21 CD B-NP O
days NNS I-NP O
, , O O
please VB B-VP O
apply VB I-VP O
twice RB B-ADVP O
a DT B-NP O
day NN I-NP O
to TO B-PP O
affected VBN B-NP O
areas NNS I-NP O
Clindamycin NNP B-NP O
1 CD I-NP O
% NN I-NP O
GEL NNP I-NP O
TOPICAL NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
x NN I-NP O
21 CD B-NP O
days NNS I-NP O
, , O O
please VB B-VP O
apply VB I-VP O
to TO B-PP O
affected VBN B-NP O
areas NNS I-NP O
twice RB B-NP O
a DT I-NP O
day NN I-NP O
Percocet NNP B-NP O
( -LRB- I-NP O
OXYCODONE+APAP NNP I-NP O
) -RRB- I-NP O
1 CD I-NP O
TAB NNP I-NP O
(5-325MG JJ I-NP O
TABLET NNP I-NP O
) -RRB- I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
PRN NNP I-NP O
pain NN I-NP O
x NN I-NP O
30 CD B-NP O
days NNS I-NP O
, , O O
do VBP B-VP O
not RB I-VP O
drive VB I-VP O
ot RB I-VP O
operate VB I-VP O
heavy JJ B-NP O
machinery NN I-NP O
while IN B-ADVP O
on IN B-PP O
med JJ B-NP O
as IN I-NP O
can MD B-VP O
make VB I-VP O
you PRP B-NP O
drowsy VB B-VP O
Lisinopril NNP B-NP O
20 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
40MG JJ I-NP O
TABLET NN I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
Zocor NNP B-NP O
( -LRB- I-NP O
SIMVASTATIN NNP B-NP O
) -RRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
40MG JJ I-NP O
TABLET NN I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QHS NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
, , O O
if IN B-SBAR O
you PRP B-NP O
develop VBP B-VP O
muscle NN B-NP O
pain NN I-NP O
or CC I-NP O
weakness NN I-NP O
, , O O
stop VB B-VP O
the DT B-NP O
drug NN I-NP O
immediately RB B-ADVP O
and CC O O
call VB B-VP O
your PRP$ B-NP O
doctor NN I-NP O
. . O O
Allergies . O O
Erythromycins NNS B-NP O
- : O O
Hives NNS B-NP O
, , O O
PE NN B-NP O
: : O O
218lbs VBZ B-VP O
140/8 CD B-NP O
0 CD I-NP O
80 CD I-NP O
12 CD O O
GENERAL NNP B-NP O
: : O O
overweight JJ B-NP O
female NN I-NP O
; : O O
appears VBZ B-VP O
relatively RB B-ADJP O
comfortable JJ I-ADJP O
at IN B-PP O
rest NN B-NP O
, , O O
but CC O O
uncomfortable JJ B-NP O
getting VBG I-NP O
on IN B-PP O
examining NN B-NP O
table NN I-NP O
HEENT NNP B-NP O
: : O O
anicteric JJ B-NP O
, , I-NP O
EOMI NNP I-NP O
, , I-NP O
PERRL NNP I-NP O
, , I-NP O
mmm NN I-NP O
, , O O
thyroid VBD B-VP O
nonpalable JJ O O
CHEST NNP B-NP O
: : O O
CTA-B NNP B-VP O
with IN B-PP O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
COR JJ B-NP O
: : O O
rrr NN B-NP O
, , O O
S1S2 NNP B-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
ABD NNP B-NP O
: : O O
obese NN B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
NTND NNP I-NP O
, , I-NP O
+BS NNP I-NP O
, , O O
EXT NNP B-NP O
: : O O
no DT B-NP O
edema NN I-NP O
DERM NN B-NP O
: : O O
L>>R NNP B-NP O
groin NN I-NP O
with IN B-PP O
significant JJ B-NP O
scar NN I-NP O
tissue NN I-NP O
and CC O O
swelling VBG B-VP O
with IN B-PP O
overlying JJ B-NP O
erythema NN I-NP O
, , O O
decreased VBD B-VP O
drainage NN B-NP O
compared VBN B-VP O
to TO B-PP O
last JJ B-NP O
visit NN I-NP O
, , O O
although IN B-PP O
still RB B-NP O
significant JJ I-NP O
tenderness NN I-NP O
to TO B-PP O
light JJ B-NP O
touch NN I-NP O
; : O O
Left VBN B-NP O
axilla NN I-NP O
with IN B-PP O
decreased VBN B-NP O
erythema NN I-NP O
and CC I-NP O
drainage NN I-NP O
, , O O
although IN B-SBAR O
still RB O O
w JJ B-NP O
significant JJ I-NP O
scar NN I-NP O
tissue NN I-NP O
, , O O
swelling VBG B-VP O
, , O O
and CC O O
mild JJ B-NP O
drainage NN I-NP O
. . O O
A/P NNP B-NP O
: : O O
48 CD B-NP B-AGE
F NN I-NP O
with IN B-PP O
PMH NNP B-NP O
of IN B-PP O
type NN B-NP O
II NNP I-NP O
DM NNP I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
hidradenitis NN B-NP O
suppurativa NN I-NP O
, , O O
and CC O O
new JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
fibromyalgia NN B-NP O
; : O O
a/p NN B-NP O
to TO B-VP O
be VB I-VP O
discussed VBN I-VP O
by IN B-PP O
each DT B-NP O
specific JJ I-NP O
issue NN I-NP O
: : O O
1 CD B-NP O
) -RRB- I-NP O
DM NNP I-NP O
: : O O
Fairly RB B-NP O
well-controlled JJ I-NP O
type NN I-NP O
II NNP I-NP O
DM NNP I-NP O
with IN B-PP O
HgbA1c NN B-NP O
of IN B-PP O
7.1 CD B-NP O
; : O O
will MD B-VP O
continue VB I-VP O
to TO I-VP O
aim VB I-VP O
for IN B-PP O
<7 CD B-NP O
. . O O
----re-checking JJ B-NP O
HgbA1c JJ I-NP O
today NN I-NP O
; : O O
consider VB B-VP O
increasing VBG B-NP O
Glucotrol JJ I-NP O
XL NNP I-NP O
from IN B-PP O
2.5 CD B-NP O
to TO B-PP O
5mg CD B-NP O
pnd JJ I-NP O
result NN I-NP O
, , O O
goal NN B-NP O
<7 IN B-PP O
% NN B-NP O
. . O O
----continue JJ B-NP O
ASA NNP I-NP O
81mg CD I-NP O
qd . O O
----Encouraged JJ B-NP O
continued VBD I-NP O
weight NN I-NP O
loss NN I-NP O
; : O O
asked VBD B-VP O
Nora NNP B-NP B-PATIENT
to TO B-VP O
keep VB I-VP O
food/calorie NN B-NP O
log NN I-NP O
to TO B-VP O
review VB I-VP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
----Re-checking JJ B-NP O
u/a NNP I-NP O
, , O O
urine NN B-NP O
microalb/crt NN I-NP O
today NN I-NP O
; : O O
ordered VBN B-NP O
last JJ I-NP O
visit NN I-NP O
, , O O
but CC O O
no DT B-NP O
results NNS I-NP O
listed VBN B-VP O
. . O O
----Increasing JJ B-NP O
lisinopril NN I-NP O
from IN B-PP O
20mg CD B-NP O
to TO B-PP O
40mg CD B-NP O
for IN B-PP O
DM NNP B-NP O
BP NNP I-NP O
goal NN I-NP O
of IN B-PP O
<130/8 CD B-NP O
0 CD I-NP O
----Confirm JJ B-NP O
results NNS I-NP O
of IN B-PP O
optho NNP B-NP O
exam NN I-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
----perform NN B-NP O
DM NNP I-NP O
foot NN I-NP O
exam NN I-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
( -LRB- I-NP O
today NN I-NP O
denies VBZ B-VP O
numbness NN B-NP O
, , O O
paresthesias NNS B-NP O
, , O O
or CC O O
loss NN B-NP O
of IN B-PP O
sensation NN B-NP O
) -RRB- I-NP O
; : O O
discussed VBN B-NP O
importance NN I-NP O
of IN B-PP O
good JJ B-NP O
foot NN I-NP O
care NN I-NP O
and CC I-NP O
cautious JJ I-NP O
nail NN I-NP O
clipping VBG I-NP O
----Given JJ B-NP O
elevated JJ I-NP O
CRP NNP I-NP O
( -LRB- I-NP O
9.0) CD I-NP O
and CC I-NP O
LDL NNP I-NP O
just RB B-ADVP O
at IN B-PP O
goal NN B-NP O
(96 CD I-NP O
) -RRB- I-NP O
, , O O
will MD B-VP O
increase VB I-VP O
Zocor NNP B-NP O
from IN B-PP O
20mg CD B-NP O
to TO I-NP O
40mg CD I-NP O
qhs NNS I-NP O
2 CD B-NP O
) -RRB- I-NP O
HTN NN I-NP O
: : O O
still RB B-ADVP O
w WRB B-ADVP O
BP NNP B-NP O
above IN B-PP O
DM NNP B-NP O
goal NN I-NP O
of IN B-PP O
<130/8 CD B-NP O
0 CD I-NP O
( -LRB- I-NP O
140/8 CD I-NP O
0 CD I-NP O
) -RRB- O O
----Increased JJ B-NP O
lisinopril NN I-NP O
to TO B-PP O
40mg CD B-NP O
qd NN I-NP O
----re-checking JJ B-NP O
chem.7 NN I-NP O
in IN B-PP O
7-10d JJ B-NP O
with IN B-PP O
lisinopril JJ B-NP O
dose NN I-NP O
increase NN I-NP O
3 CD B-NP O
) -RRB- I-NP O
hidradenitis NN I-NP O
suppurativa NN I-NP O
: : O O
----Will NN B-NP O
re-contact NN I-NP O
gen NN I-NP O
surgery NN I-NP O
re NN I-NP O
: : O O
their PRP$ B-NP O
advice NN I-NP O
(attempt NN I-NP O
to TO B-VP O
locate VB I-VP O
note NN B-NP O
from IN B-PP O
visit NN B-NP O
) -RRB- O O
----will NNP B-NP O
also RB B-ADVP O
contact NN B-VP O
plastics NNS B-NP O
to TO B-VP O
discuss VB I-VP O
coverage NN B-NP O
for IN B-PP O
a DT B-NP O
procedure NN I-NP O
that WDT B-NP O
is VBZ B-VP O
clearly RB B-ADVP O
not RB O O
cosmetic JJ O O
----concerned JJ B-ADJP O
about IN B-PP O
possible JJ B-NP O
resistance NN I-NP O
to TO B-PP O
different JJ B-NP O
abx NN I-NP O
, , O O
but CC O O
need VBP B-VP O
to TO I-VP O
treat VB I-VP O
until IN B-PP O
more JJR B-NP O
definitive JJ I-NP O
surgical JJ I-NP O
treatment NN I-NP O
; : O O
( -LRB- B-NP O
wrote VBD B-VP O
script NN B-NP O
for IN B-PP O
levo NN B-NP O
for IN B-PP O
recurrent JJ B-NP O
inflammation NN I-NP O
; : O O
told VBD B-NP O
Nora NNP I-NP B-PATIENT
that IN B-SBAR O
she PRP B-NP O
had VBD B-VP O
to TO I-VP O
call VB I-VP O
me PRP B-NP O
to TO B-VP O
let VB I-VP O
me PRP B-NP O
know VB B-VP O
if IN B-SBAR O
she PRP B-NP O
needs VBZ B-VP O
to TO I-VP O
use VB I-VP O
it PRP B-NP O
, , O O
but CC O O
concerned JJ B-NP O
bc NN I-NP O
last JJ B-NP O
time NN I-NP O
she PRP B-NP O
was VBD B-VP O
unable JJ B-ADJP O
to TO B-VP O
get VB I-VP O
to TO I-VP O
PICH VB I-VP B-HOSPITAL
until IN B-PP O
inflammation NN B-NP O
quite RB B-ADJP O
severe JJ I-ADJP O
) -RRB- O O
4 CD B-NP O
) -RRB- I-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
ovarian JJ B-NP O
cancer NN I-NP O
: : O O
strong JJ B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
ovarian JJ B-NP O
cancer NN I-NP O
( -LRB- I-NP O
sister NN I-NP O
, , O O
mother NN B-NP O
, , O O
and CC O O
maternal JJ B-NP O
GM NNP I-NP O
all DT O O
died VBD B-VP O
from IN B-PP O
ovarian JJ B-NP O
cancer NN I-NP O
) -RRB- B-VP O
; : I-VP O
previously RB I-VP O
scheduled VBN I-VP O
to TO I-VP O
see VB I-VP O
Dr. NNP B-NP O
Crowley NNP I-NP B-DOCTOR
at IN B-PP O
MTCI NNP B-NP B-HOSPITAL
on IN B-PP O
2/12/8 CD B-NP I-DATE
0 CD I-NP I-DATE
, , O O
but CC O O
pt VBD B-VP O
never RB I-VP O
received VBN I-VP O
appt JJ B-NP O
letter NN I-NP O
bc VBG I-NP O
address NN I-NP O
changed VBD B-VP O
. . O O
----re-scheduled JJ B-NP O
appt NN I-NP O
with IN B-PP O
high JJ B-NP O
risk NN I-NP O
ovarian NN I-NP O
cancer NN I-NP O
clinic NN I-NP O
at IN B-PP O
the DT B-NP O
MTCI NNP I-NP B-HOSPITAL
5 CD B-NP O
) -RRB- I-NP O
tobacco NN I-NP O
cessation NN I-NP O
: : O O
stressed VBD B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
tobacco NN B-NP O
cessation NN I-NP O
to TO B-PP O
Nora NNP B-NP B-PATIENT
for IN B-PP O
her PRP$ B-NP O
heart NN I-NP O
, , O O
cancer NN B-NP O
risk NN I-NP O
, , O O
pulmonary JJ B-NP O
health NN I-NP O
, , O O
and CC O O
overall JJ B-NP O
health NN I-NP O
. . O O
She PRP B-NP O
expressed VBD B-VP O
sincere JJ B-NP O
interest NN I-NP O
in IN B-PP O
quitting VBG B-VP O
smoking NN B-NP O
today NN I-NP O
. . O O
---Will NN B-NP O
refer VBP B-VP O
to TO B-PP O
Otha NNP B-NP B-DOCTOR
Rush NNP I-NP I-DOCTOR
for IN B-PP O
smoking VBG B-VP O
cessation NN B-NP O
education NN I-NP O
---Mentioned JJ B-NP O
nicotine JJ I-NP O
patches NNS I-NP O
, , O O
gum NN B-NP O
, , O O
etc FW B-NP O
, , O O
but CC O O
Nora NNP B-NP B-PATIENT
felt VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
wanted VBD B-VP O
to TO I-VP O
try VB I-VP O
to TO I-VP O
stop VB I-VP O
without IN B-PP O
anything NN B-NP O
for IN B-PP O
now RB B-NP O
; : O O
will MD B-VP O
consider VB I-VP O
these DT B-NP O
options NNS I-NP O
, , O O
if IN B-PP O
struggling VBG B-NP O
. . O O
6 CD B-NP O
) -RRB- I-NP O
FIBROMYALGIA/ NNP I-NP O
JOINT NNP I-NP O
PAINS NNS I-NP O
: : O O
----will JJ B-NP O
f/u NN I-NP O
with IN B-PP O
rheum NN B-NP O
Dr. NNP I-NP O
Marshall NNP I-NP B-DOCTOR
7 CD B-NP O
) -RRB- I-NP O
? . I-NP O
Seizures NNP I-NP O
: : O O
discussed VBN B-VP O
"d JJ B-NP O
j NN I-NP O
vu NN I-NP O
" `` I-NP O
sensation NN I-NP O
that IN B-PP O
last JJ B-NP O
for IN B-PP O
minutes NNS B-NP O
and CC O O
then RB B-VP O
resolves VBZ I-VP O
similar JJ B-ADJP O
to TO B-PP O
prior JJ B-NP O
seizures NNS I-NP O
with IN B-PP O
NP NNP B-NP O
; : O O
never RB B-VP O
mentioned VBN I-VP O
to TO B-PP O
me PRP B-NP O
; : O O
will MD B-VP O
need VB I-VP O
to TO I-VP O
f/u VB I-VP O
symptoms NNS B-NP O
and CC O O
neurology NN B-NP O
appointment NN I-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
. . O O
8 CD B-NP O
) -RRB- I-NP O
HCM . I-NP O
: : O O
----PAP JJ B-NP O
SMEAR NNP I-NP O
: : O O
Pt NNP B-NP O
overdue JJ I-NP O
for IN B-PP O
pap NN B-NP O
; : O O
once RB B-NP O
again RB B-ADVP O
asked VBD B-VP O
to TO B-VP O
defer VB I-VP O
given VBN I-VP O
severe JJ B-NP O
pain NN I-NP O
2/2 IN B-PP O
HS NNP B-NP O
; : O O
will MD B-VP O
continue VB I-VP O
to TO I-VP O
offer VB I-VP O
. . O O
----MAMMOGRAM NN B-NP O
: : O O
Scheduled VBN B-VP O
on IN B-PP O
several JJ B-NP O
occasions NNS I-NP O
, , O O
but CC O O
never RB B-VP O
obtained VBN I-VP O
; : O O
re-scheduling JJ B-NP O
today NN I-NP O
. . O O
----LIPIDS NNP B-NP O
: : O O
12/31/79 CD B-NP B-DATE
: : O O
TCHOL NNP B-NP O
: : O O
183 CD B-NP O
; : O O
TRIG NNP B-NP O
: : O O
183 CD B-NP O
; : O O
HDL NNP B-NP O
: : O O
50 CD B-NP O
; : O O
LDL:96 CD O O
----Continue JJ B-ADJP O
to TO B-VP O
screen VB I-VP O
for IN B-PP O
DV NNP B-NP O
and CC I-NP O
safety NN I-NP O
level NN I-NP O
: : O O
negative JJ B-NP O
today NN I-NP O
. . O O
Pt NNP B-ADJP O
to TO B-VP O
RTC NNP B-NP O
in IN B-PP O
3 CD B-NP O
mos CD I-NP O
or CC O O
sooner RB B-ADVP O
as IN B-SBAR O
needed VBN B-VP O
. . O O
Pt NNP B-NP O
was VBD B-VP O
presented VBN I-VP O
to TO B-NP O
and CC I-NP O
plan NN I-NP O
discussed VBN B-VP O
with IN B-PP O
attg NN B-NP O
, , O O
Dr. NNP B-NP O
Ula NNP I-NP B-DOCTOR
Lovett NNP I-NP I-DOCTOR
. . O O
Gina NNP B-NP B-DOCTOR
Kevin NNP I-NP I-DOCTOR
Irons NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
